focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHiscox Regulatory News (HSX)

Share Price Information for Hiscox (HSX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,170.00
Bid: 1,168.00
Ask: 1,170.00
Change: -12.00 (-1.02%)
Spread: 2.00 (0.171%)
Open: 1,176.00
High: 1,186.00
Low: 1,166.00
Prev. Close: 1,182.00
HSX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on Hurricanes Harvey and Irma

2 Oct 2017 07:00

RNS Number : 3278S
Hiscox Ltd
02 October 2017
 

 

 

Update on Hurricanes Harvey and Irma

Hamilton, Bermuda (Monday 2nd October 2017) - Hiscox Ltd (LSE:HSX), the international specialist insurer, has undertaken a first estimate of the combined impact of Hurricane Harvey and Hurricane Irma.

 

Due to the interrelated nature of reinsurance recoveries for these two events, the Group is disclosing a combined figure. Based on an insured market loss of US$35 billion for Hurricane Irma and US$25 billion for Hurricane Harvey (excluding the government backed National Flood Insurance Program), Hiscox estimates combined net claims of approximately US$225 million. Although there is still a degree of uncertainty around these hurricanes, this is within the Group's modelled range of claims for events of this nature, and we still have depth of cover in our reinsurance programme.

 

Hiscox Group CEO, Bronek Masojada, said: "Paying claims from devastating events like these is precisely what we are here for. Our focus is to get our customers back on their feet as quickly as we can."

 

Bronek added: "These events are already having an impact on rates in the global insurance market, particularly in affected areas and specific sectors. After a number of years of rate reductions, we are starting to see price corrections, most acutely in affected lines such as large property insurance and catastrophe reinsurance, which we expect to spread to non-affected lines. Although these are huge insured events, sadly, they also highlight the lack of cover in places."

 

Hiscox will publish a Q3 Interim Management Statement on 7 November.

 

Ends

 

 

 

For further information please contact:

 

Hiscox Ltd

Kylie O'Connor +44 (0) 20 7448 6656 Kylie.O'Connor@HISCOX.com

Lucy Hensher +44 (0) 20 7448 6619 Lucy.Hensher@HISCOX.com

 

Brunswick

Tom Burns +44 (0)20 7404 5959 TBurns@BrunswickGroup.com

Simone Selzer +44 (0)20 7404 5959 SSelzer@BunswickGroup.com

 

 

 

 

Notes to editors

 

About The Hiscox Group

Hiscox is a global specialist insurer, headquartered in Bermuda and listed on the London Stock Exchange (LSE:HSX). Our ambition is to be a respected specialist insurer with a diverse portfolio by product and geography. We believe that building balance between catastrophe-exposed business and less volatile local specialty business gives us opportunities for profitable growth throughout the insurance cycle. It's a long-standing strategy which in 2016 helped generate gross premiums written of £2,402.6 million and a record profit before tax of £354.5 million.

 

The Hiscox Group employs over 2,300 people in 13 countries, and has customers worldwide. Through the retail businesses in the UK, Europe, Asia and the US, we offer a range of specialist insurance for professionals and business customers as well as homeowners. Internationally traded, bigger ticket business and reinsurance is underwritten through Hiscox London Market and Hiscox Re and ILS.

 

Our values define our business, with a focus on people, quality, courage and excellence in execution. We pride ourselves on being true to our word and our award-winning claims service is testament to that. For more information, visit www.hiscoxgroup.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBRGDCUGDBGRC
Date   Source Headline
19th Mar 20247:00 amRNSTransaction in Own Shares
18th Mar 20247:00 amRNSTransaction in Own Shares
15th Mar 20247:00 amRNSTransaction in Own Shares
14th Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 20247:00 amRNSTransaction in Own Shares
12th Mar 20247:00 amRNSTransaction in Own Shares
11th Mar 20247:00 amRNSTransaction in Own Shares
8th Mar 20247:00 amRNSTransaction in Own Shares
7th Mar 20247:30 amRNSSyndicates 33 and 6104 – results and estimates
7th Mar 20247:00 amRNSTransaction in Own Shares
6th Mar 20247:00 amRNSTransaction in Own Shares
5th Mar 20247:01 amRNSAnnouncement of share repurchase programme
5th Mar 20247:00 amRNSFull Year Results
19th Feb 20245:48 pmRNSTR-1 Standard form-notification major shareholding
1st Feb 20244:34 pmRNSTotal Voting Rights
8th Jan 20243:07 pmRNSTotal Voting Rights
12th Dec 20234:44 pmRNSDirector/PDMR Shareholding
1st Dec 20234:40 pmRNSTotal Voting Rights
10th Nov 202311:30 amRNSSyndicates 33 and 6104 – results and estimates
8th Nov 20237:00 amRNSQ3 2023 Trading Statement
1st Nov 20235:20 pmRNSTotal Voting Rights
2nd Oct 20234:47 pmRNSTotal Voting Rights
27th Sep 20237:00 amRNSDivestment of DirectAsia
25th Sep 202312:30 pmRNSDirector/PDMR Shareholding
25th Sep 20239:00 amRNSApplication to be admitted to the Official List
12th Sep 20235:22 pmRNSAnnouncement of Scrip Reference Share Price
1st Sep 20237:00 amRNSDirector/PDMR Shareholding
11th Aug 20237:30 amRNSSyndicates 33 and 6104 - results and estimates
10th Aug 20237:00 amRNSDirector/PDMR Shareholding
4th Jul 20231:23 pmRNSTotal Voting Rights
21st Jun 20233:23 pmRNSDirector/PDMR Shareholding
16th Jun 202312:35 pmRNSDirector PDMR Shareholding
14th Jun 20231:19 pmRNSStandard form for notification of major holdings
13th Jun 20232:28 pmRNSDirector/PDMR Shareholding
9th Jun 20231:56 pmRNSApplication to be Admitted to Official List
9th Jun 202312:19 pmRNSApplication to be Admitted to Official List
8th Jun 20237:00 amRNSIFRS 17 restated results 2022
1st Jun 20235:10 pmRNSTotal Voting Rights
1st Jun 202312:12 pmRNSAnnouncement of Scrip Reference Share Price
30th May 20234:05 pmRNSDirector/PDMR Shareholding
30th May 20237:00 amRNSHiscox appoints Jonathan Bloomer Chair designate
23rd May 20233:26 pmRNSTR-1:Standard form-notification major shareholding
22nd May 202312:25 pmRNSTR-1:Standard form-notification major shareholding
15th May 20231:01 pmRNSSyndicates 33 and 6104 – results and estimates
12th May 20237:01 amRNSHiscox appoints new Independent Non Exec Director
12th May 20237:00 amRNSAGM RESULTS
11th May 20235:33 pmRNSTR-1 Standard form-notification major shareholding
9th May 202312:23 pmRNSTR-1:Standard form-notification major shareholding
4th May 20237:00 amRNSQ1 2023 Trading Statement
2nd May 20235:00 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.